000 | 01987 a2200541 4500 | ||
---|---|---|---|
005 | 20250515112829.0 | ||
264 | 0 | _c20080701 | |
008 | 200807s 0 0 eng d | ||
022 | _a0014-2999 | ||
024 | 7 |
_a10.1016/j.ejphar.2008.02.027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSarre, Sophie | |
245 | 0 | 0 |
_aIn vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cApr 2008 |
||
300 |
_a297-305 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
650 | 0 | 4 |
_aAdamantane _xadministration & dosage |
650 | 0 | 4 |
_aAmidines _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
650 | 0 | 4 |
_aBasal Ganglia _xdrug effects |
650 | 0 | 4 | _aDenervation |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aDopamine Agents _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMedial Forebrain Bundle _xdrug effects |
650 | 0 | 4 | _aMicrodialysis |
650 | 0 | 4 | _aOxidopamine |
650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
650 | 0 | 4 | _aPerfusion |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aLanza, Marco | |
700 | 1 | _aMakovec, Francesco | |
700 | 1 | _aArtusi, Roberto | |
700 | 1 | _aCaselli, Gianfranco | |
700 | 1 | _aMichotte, Yvette | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 584 _gno. 2-3 _gp. 297-305 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2008.02.027 _zAvailable from publisher's website |
999 |
_c17843893 _d17843893 |